US5770198A
(en)
*
|
1988-05-18 |
1998-06-23 |
The Research Foundation Of The State Of New York |
Platelet-specific chimeric 7E3 immunoglobulin
|
US5169930A
(en)
*
|
1990-01-05 |
1992-12-08 |
La Jolla Cancer Research Foundation |
Fibronectin receptor
|
US7132260B2
(en)
*
|
1991-04-05 |
2006-11-07 |
The General Hospital Corporation |
DNA encoding parathyroid hormone receptor
|
CA2107569C
(en)
*
|
1991-04-05 |
2011-08-02 |
Gino V. Segre |
Parathyroid hormone receptor and dna encoding same
|
US7150974B1
(en)
|
1991-04-05 |
2006-12-19 |
The General Hospital Corporation |
Parathyroid hormone receptor binding method
|
JPH08505628A
(ja)
*
|
1993-01-08 |
1996-06-18 |
田辺製薬株式会社 |
ペプチド型細胞接着阻害薬
|
AU6235294A
(en)
*
|
1993-02-02 |
1994-08-29 |
Scripps Research Institute, The |
Methods for producing polypeptide binding sites
|
US5753230A
(en)
*
|
1994-03-18 |
1998-05-19 |
The Scripps Research Institute |
Methods and compositions useful for inhibition of angiogenesis
|
US6056958A
(en)
*
|
1994-12-09 |
2000-05-02 |
Dupont Pharmaceuticals |
Method of treatment of arterial and venous thromboembolic disorders
|
DK0719859T3
(da)
*
|
1994-12-20 |
2003-10-20 |
Merck Patent Gmbh |
Anti-alfa V-integrin monoklonalt antistof
|
US5817768A
(en)
*
|
1995-06-07 |
1998-10-06 |
The New York Blood Center, Inc. |
Monospecific antibodies against a subunit of fibrinogen
|
SK163598A3
(en)
|
1996-05-31 |
1999-06-11 |
Scripps Research Inst |
Methods and compositions useful for inhibition of angiogenesis
|
WO1998009651A1
(fr)
*
|
1996-09-03 |
1998-03-12 |
Chugai Seiyaku Kabushiki Kaisha |
COMPLEXES D'ANTICORPS ANTI-INTEGRINE α3
|
EP0846702B1
(de)
*
|
1996-12-09 |
2009-03-11 |
MERCK PATENT GmbH |
Löslicher, rekombinanter alphaV beta3 Adhäsionsrezeptor
|
US6590079B2
(en)
*
|
1997-01-30 |
2003-07-08 |
Ixsys, Incorporated |
Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same
|
US20010011125A1
(en)
*
|
1997-01-30 |
2001-08-02 |
William D. Huse |
Anti-alpha v beta 3 recombinant human antibodies, nucleic acids encoding same and methods of use
|
US6596850B1
(en)
*
|
1998-01-30 |
2003-07-22 |
Ixsys, Incorporated |
Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same
|
JP2002508656A
(ja)
|
1997-03-12 |
2002-03-19 |
スミスクライン・ビーチャム・コーポレイション |
抗−アルファベータ3ヒト化モノクローナル抗体
|
WO1998046265A1
(en)
*
|
1997-04-11 |
1998-10-22 |
G.D. Searle & Co. |
Methods for using antagonistic anti-avb3 integrin antibodies
|
PT973550E
(pt)
|
1997-04-11 |
2003-01-31 |
Searle & Co |
Anticorpos antagonistas anti-integrina avb3
|
US6210904B1
(en)
*
|
1997-10-14 |
2001-04-03 |
Merck & Co., Inc. |
Anticoagulant test
|
DE19828068C2
(de)
*
|
1998-06-24 |
2003-12-18 |
Peter Dietsch |
Mittel zur spezifischen Hemmung osteoklastärer Knochenresorption
|
EP1104304A1
(de)
*
|
1998-08-13 |
2001-06-06 |
G.D. Searle & Co. |
Multivalent avb3 und ligande für metastasis-assoziierte receptoren
|
IL143514A0
(en)
*
|
1998-12-04 |
2002-04-21 |
Novartis Ag |
METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ3
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
US7049140B1
(en)
|
1999-04-29 |
2006-05-23 |
Vanderbilt University |
X-ray guided drug delivery
|
US6159443A
(en)
*
|
1999-04-29 |
2000-12-12 |
Vanderbilt University |
X-ray guided drug delivery
|
US6531580B1
(en)
|
1999-06-24 |
2003-03-11 |
Ixsys, Inc. |
Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same
|
US6037176A
(en)
*
|
1999-06-25 |
2000-03-14 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of integrin beta 3 expression
|
EP1235595B8
(de)
*
|
1999-09-08 |
2009-10-07 |
Bayer Schering Pharma Aktiengesellschaft |
Integrin-vermittelte arzneimittel-zielrichtung
|
ES2197885T3
(es)
*
|
1999-10-28 |
2004-01-16 |
Hofbauer, Reinhold |
Uso de inhibidores csf-1.
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
ES2260234T3
(es)
*
|
2000-05-12 |
2006-11-01 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. |
Utilizacion de inhibidores del factor de crecimiento placentario para el tratamiento de la angiogenesis patologica, de la arteriogenesis patologica, de la inflamacion, de la formacion tumoral y/o de la perdida vascular.
|
US7163681B2
(en)
|
2000-08-07 |
2007-01-16 |
Centocor, Inc. |
Anti-integrin antibodies, compositions, methods and uses
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
US7220824B1
(en)
|
2000-08-28 |
2007-05-22 |
Bayer Aktiengesellschaft |
Integrin-mediated drug targeting
|
EP1219305A1
(de)
*
|
2000-12-27 |
2002-07-03 |
Bayer Aktiengesellschaft |
Konjugate von Integrinrezeptorantagonisten und einem zytostatischen Mittel mit spezifisch spaltbaren Linkergruppen
|
CN1507354A
(zh)
*
|
2001-03-02 |
2004-06-23 |
ͨ��ҽ�ƹ�˾ |
通过给予整合蛋白αvβ3拮抗剂并与其它预防或治疗药剂配合来预防或者治疗炎性疾病或自身免疫疾病的方法
|
US7306925B2
(en)
|
2001-11-09 |
2007-12-11 |
Vanderbilt University |
Phage antibodies to radiation-inducible neoantigens
|
US7906102B2
(en)
|
2001-10-03 |
2011-03-15 |
Vanderbilt University |
Ligands to radiation-induced molecules
|
WO2003075957A1
(en)
*
|
2002-03-04 |
2003-09-18 |
Medimmune, Inc. |
The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
|
JP2005525368A
(ja)
*
|
2002-03-04 |
2005-08-25 |
メディミューン,インコーポレーテッド |
インテグリンαvβ3アンタゴニストをHMG−CoA還元酵素阻害剤またはビスフォスフォネートと併用投与する障害の予防または治療方法
|
EP1499352A4
(de)
*
|
2002-04-12 |
2006-10-11 |
Medimmune Inc |
Rekombinante anti-interleukin-9-antikörper
|
DE60312684T2
(de)
*
|
2002-06-28 |
2007-12-06 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. |
Plazenta-wachstumsfaktor als target für die behandlung von osteoporose
|
US20050186204A1
(en)
*
|
2002-06-28 |
2005-08-25 |
Peter Carmeliet |
Use of antibodies against FLT-1 for the treatment of osteoporosis
|
CA2514653A1
(en)
*
|
2003-01-30 |
2004-08-12 |
Medimmune, Inc. |
Uses of integrin alphavbeta3 antagonists
|
AU2004229501B2
(en)
|
2003-04-11 |
2011-08-18 |
Medimmune, Llc |
Recombinant IL-9 antibodies and uses thereof
|
WO2005044978A2
(en)
*
|
2003-07-15 |
2005-05-19 |
Washington University |
Methods of treating, preventing and inhibiting cancer metastasis and tumor formation
|
US7271245B2
(en)
*
|
2004-02-13 |
2007-09-18 |
The Scripps Research Institute |
Methods and compositions for inhibition of metastasis
|
US7351739B2
(en)
*
|
2004-04-30 |
2008-04-01 |
Wellgen, Inc. |
Bioactive compounds and methods of uses thereof
|
US8187595B2
(en)
*
|
2004-05-07 |
2012-05-29 |
The University Of North Carolina At Chapel Hill |
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-I
|
DK1755660T3
(da)
*
|
2004-05-07 |
2010-07-19 |
Univ North Carolina |
Fremgangsmåde til forbedring eller hæmning af insulin-lignende vækstfaktor-I
|
EP3130349A1
(de)
|
2004-06-04 |
2017-02-15 |
Genentech, Inc. |
Verfahren zur behandlung von multipler sklerose
|
EP2422811A2
(de)
|
2004-10-27 |
2012-02-29 |
MedImmune, LLC |
Modulation von Antikörperspezifität mittels Anpassung der Affinität zu verwandten Antigenen
|
EP1869085B1
(de)
|
2005-03-24 |
2012-03-14 |
ThromboGenics N.V. |
Neuer anti-plgf-antikörper
|
EP1904095B1
(de)
*
|
2005-06-30 |
2013-05-29 |
VIB, vzw |
Behandlung von leberzirrhose und ihre komplikationen
|
MY149159A
(en)
|
2005-11-15 |
2013-07-31 |
Hoffmann La Roche |
Method for treating joint damage
|
WO2008011216A2
(en)
*
|
2006-05-16 |
2008-01-24 |
Pro-Pharmaceuticals, Inc. |
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
|
AU2007272970C1
(en)
|
2006-07-11 |
2013-01-10 |
Roy C. Levitt |
Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
|
EP2079483A4
(de)
*
|
2006-07-29 |
2010-10-20 |
Robert Lamar Bjork Jr |
Bispezifische monoklonale antikörper (spezifisch für cd3 und cd11b)-therapeutische arzneimittelsysteme
|
CA3177366A1
(en)
|
2006-08-10 |
2008-02-21 |
Roy C. Levitt |
Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
|
TW201014605A
(en)
|
2008-09-16 |
2010-04-16 |
Genentech Inc |
Methods for treating progressive multiple sclerosis
|
JP5522717B2
(ja)
*
|
2008-09-19 |
2014-06-18 |
国立大学法人佐賀大学 |
アトピー性皮膚炎の検出方法および予防・治療剤のスクリーニング方法
|
DK2352761T3
(en)
|
2008-10-02 |
2016-10-03 |
Vib Vzw |
INHIBITION OF PLGF TO TREAT PHILADELPHIA CHROMOSOMPOSITIVE LEUKEMIS
|
WO2010075249A2
(en)
|
2008-12-22 |
2010-07-01 |
Genentech, Inc. |
A method for treating rheumatoid arthritis with b-cell antagonists
|
EP2374002A1
(de)
*
|
2008-12-23 |
2011-10-12 |
GE Healthcare UK Limited |
Anwendung einer auf 99mtc-peptid basierenden verbindung als knochenmark-bildgebungsmittel
|
HRP20221259T1
(hr)
|
2009-02-13 |
2022-12-09 |
Immunomedics, Inc. |
Imunokonjugati s intracelularnom vezom koja se može rascijepiti
|
IN2012DN01663A
(de)
|
2009-09-16 |
2015-06-05 |
Immunomedics Inc |
|
ES2978177T3
(es)
|
2009-12-02 |
2024-09-06 |
Immunomedics Inc |
Combinación de radio inmunoterapia y conjugados anticuerpo-fármaco para mejorar la terapia contra el cáncer
|
CA2831572C
(en)
|
2011-05-02 |
2019-11-26 |
Immunomedics, Inc. |
Ultrafiltration concentration of allotype selected antibodies for small-volume administration
|
ES2628321T3
(es)
|
2011-12-01 |
2017-08-02 |
Thrombogenics N.V. |
Mejora del resultado de una trabeculectomía
|
WO2013101771A2
(en)
|
2011-12-30 |
2013-07-04 |
Genentech, Inc. |
Compositions and method for treating autoimmune diseases
|
SG11201404486QA
(en)
|
2012-01-31 |
2014-11-27 |
Genentech Inc |
Anti-ig-e m1' antibodies and methods using same
|
US9315567B2
(en)
|
2012-08-14 |
2016-04-19 |
Ibc Pharmaceuticals, Inc. |
T-cell redirecting bispecific antibodies for treatment of disease
|
JP2015533117A
(ja)
*
|
2012-08-31 |
2015-11-19 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
インスリン様成長因子1(igf−1)を増強または阻害するためのモノクローナル抗体
|
HUE057977T2
(hu)
|
2012-12-13 |
2022-06-28 |
Immunomedics Inc |
Ellenanyagok és SN-38 immunkonjugátumainak dózisai javított hatásossággal és csökkentett toxicitással
|
US9339515B2
(en)
|
2013-02-20 |
2016-05-17 |
Galectin Therapeutics, Inc. |
Method for treatment of pulmonary fibrosis
|
CA2937236C
(en)
|
2014-02-21 |
2023-03-07 |
Ibc Pharmaceuticals, Inc. |
Disease therapy by inducing immune response to trop-2 expressing cells
|
EP3110445A4
(de)
|
2014-02-25 |
2017-09-27 |
Immunomedics, Inc. |
Humanisierter rfb4-anti-cd22-antikörper
|
WO2015200260A1
(en)
|
2014-06-24 |
2015-12-30 |
Immunomedics, Inc. |
Anti-histone therapy for vascular necrosis in severe glomerulonephritis
|
WO2016014939A1
(en)
|
2014-07-24 |
2016-01-28 |
Washington University |
Compositions targeting radiation-induced molecules and methods of use thereof
|
PL3204018T3
(pl)
|
2014-10-07 |
2022-01-03 |
Immunomedics, Inc. |
Neoadiuwantowe zastosowanie koniugatów przeciwciało-lek
|
CA2981543A1
(en)
|
2015-04-22 |
2016-10-27 |
Immunomedics, Inc. |
Isolation, detection, diagnosis and/or characterization of circulating trop-2-positive cancer cells
|
PL3313443T3
(pl)
|
2015-06-25 |
2023-11-06 |
Immunomedics, Inc. |
Łączenie przeciwciał anty-hla-dr lub anty-trop-2 z inhibitorami mikrotubuli, inhibitorami parp, 5 inhibitorami kinazy brutona lub inhibitorami 3-kinazy fosfoinozytydu istotnie poprawia wynik terapeutyczny nowotworu
|
SI3316885T1
(sl)
|
2015-07-01 |
2021-09-30 |
Immunomedics, Inc. |
Imunokonjugati protitelo-SN-38 z linkerjem CL2A
|
KR20180075537A
(ko)
|
2015-10-06 |
2018-07-04 |
제넨테크, 인크. |
다발성 경화증을 치료하기 위한 방법
|
EP3207937A1
(de)
|
2016-02-17 |
2017-08-23 |
Royal College of Surgeons in Ireland |
Verfahren zur behandlung oder prävention von sepsis
|
KR102101561B1
(ko)
*
|
2018-07-25 |
2020-04-20 |
가톨릭대학교 산학협력단 |
신생혈관 표적용 조영제 조성물 및 이의 제조방법
|
CN113557246B
(zh)
*
|
2019-07-24 |
2023-09-01 |
韩国基础科学支援研究院 |
靶向αvβ3整联蛋白的单域抗体
|
CA3208998A1
(en)
|
2021-01-22 |
2022-07-28 |
Steven Kerrigan |
Treatment of coronavirus
|
WO2022239720A1
(ja)
|
2021-05-10 |
2022-11-17 |
公益財団法人川崎市産業振興財団 |
抗原への結合親和性を低減させた抗体
|